At a glance
- Originator Pfizer
- Developer Pfizer; Sankyo
- Class Neuroprotectants; Nootropics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 21 Jan 1997 Discontinued-Clinical for Cognition disorders in Austria (PO)